TLD-1
Showing 1 - 25 of >10,000
Emergence of HIV Drug Resistance Following Initiation of TLD
Recruiting
- HIV-1-infection
-
Port-au-Prince, Bicentaire, Haiti
- +13 more
Feb 22, 2022
HIV/AIDS, Tuberculosis, Pulmonary Trial in Durban (Biktarvy®, TLD- fixed-drug combination single tablet)
Recruiting
- HIV/AIDS
- Tuberculosis, Pulmonary
- Biktarvy®
- TLD- fixed-drug combination single tablet
-
Durban, KwaZulu-Natal, South AfricaCAPRISA Springfield Clinical Research Site
Mar 14, 2022
Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG Trial in Canada, United States (TLD-1433 Bladder infusion and
Recruiting
- Non-Muscle Invasive Bladder Cancer (NMIBC) Refractory to BCG
- TLD-1433 Bladder infusion and Photodynamic Therapy
-
Bala-Cynwyd, Pennsylvania
- +10 more
May 6, 2022
COPD Trial in Chengdu (TLD, Sham TLD procedure, Standard of care)
Not yet recruiting
- COPD
- TLD
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital of Sichuan University
Apr 3, 2023
Dolutegravir Implementation in Sub-Saharan Africa
Recruiting
- HIV-1-infection
- This is an observational study only.
-
Somkele, KwaZulu-Natal, South Africa
- +1 more
Feb 15, 2022
HIV, AIDS, Virologic Failure Trial (Maintenance on TLD treatment strategy, Individualized Care treatment strategy, Immediate
Not yet recruiting
- HIV Infections
- +2 more
- Maintenance on TLD treatment strategy
- +2 more
- (no location specified)
May 9, 2022
COPD Trial in Worldwide (Targeted Lung Denervation (TLD), Optimal Medical Care)
Recruiting
- COPD
- Targeted Lung Denervation (TLD)
- Optimal Medical Care
-
Birmingham, Alabama
- +32 more
May 9, 2022
Dolutegravir Trial in Johannesburg (CHARACTERISE)
Enrolling by invitation
- Dolutegravir
- CHARACTERISE
-
Johannesburg, Gauteng, South AfricaSunnyside Office Park
Aug 12, 2022
COPD Trial (Targeted Lung Denervation)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Targeted Lung Denervation
- (no location specified)
Jul 21, 2023
Pediatric Obesity Trial (Building Healthy Families)
Not yet recruiting
- Pediatric Obesity
- Building Healthy Families
- (no location specified)
May 3, 2021
Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)
Not yet recruiting
- Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
- (no location specified)
Feb 27, 2023
Hyperpolarized Xenon Functional Lung Imaging in COPD Patients
Not yet recruiting
- COPD
- Functional imaging of the lungs using MagniXene (hyperpolarized xenon-129) MRI
- (no location specified)
Apr 3, 2023
HIV Trial in Cape Town (Doravirine, Dolutegravir)
Not yet recruiting
- HIV
-
Cape Town, South AfricaDesmond Tutu Health Foundation
Nov 18, 2022
Can Undetectable = Untransmissible Change Life Course of
Recruiting
- HIV/AIDS
-
Harare, ZimbabweBeatrice Road Infectious Hospital
Oct 14, 2022
High-risk Leukemias Trial in Spain (NK cells stimulated ex vivo with IL-15, Alloreactive NK cells)
Recruiting
- High-risk Leukemias
- NK cells stimulated ex vivo with IL-15
- Alloreactive NK cells
-
Santiago De Compostela, A Coruña, Spain
- +9 more
Mar 30, 2022
Radiation Exposure Trial in Helsinki (Zero-Gravity, Conventional radiation protection)
Completed
- Radiation Exposure
- Zero-Gravity
- Conventional radiation protection
-
Helsinki, FinlandHelsinki University Hospital
May 12, 2021
Spinal Tumor, Traumatic Injury of Spine, Degenerative Spine Disease Trial in Taipei ("Anatase" Spine Surgery Navigation System,
Recruiting
- Spinal Tumor
- +2 more
- "Anatase" Spine Surgery Navigation System
- Medtronic Stealthstation S7 Treatment Guidance System
-
Taipei, TaiwanTaipei Veterans General Hospital
Nov 17, 2020
Airway Microenvironment in Patients Undergoing Surgical and
Recruiting
- Chronic Obstructive Pulmonary Disease
- +2 more
-
London, Chelsea, United Kingdom
- +1 more
Sep 14, 2021
Lung Tumor, Thoracoscopic Surgery Trial in Taoyuan (localization)
Recruiting
- Lung Tumor
- Thoracoscopic Surgery
- localization
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Jul 23, 2021
Crystalline Exposition During Pediatric Cranial CT Imaging
Completed
- Any Pathology Requiring a Cranial CT Imaging
- use or non-use of dose modulator and bismuth mask
-
Bordeaux, FranceCHU Bordeaux
Oct 28, 2020
Rheumatoid Arthritis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, )
Completed
- Rheumatoid Arthritis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 24, 2023
COVID-19 Trial in Thái Bình (COVIVAC vaccine)
Completed
- COVID-19
- COVIVAC vaccine
-
Thái Bình, Thai Binh, VietnamDistrict Health Center of Vu Thu District
Jul 12, 2023
Ankylosing Spondylitis Trial in Beijing (LNK01001 Dose A, LNK01001 Dose B, Placebo)
Completed
- Ankylosing Spondylitis
- LNK01001 Dose A
- +2 more
-
Beijing, ChinaPeking Union Medical College Hospital
Oct 10, 2023
Relapsing Remitting Multiple Sclerosis Trial (PIPE-307 Dose A, PIPE-307 Dose B, Placebo)
Not yet recruiting
- Relapsing Remitting Multiple Sclerosis
- PIPE-307 Dose A
- +2 more
- (no location specified)
Oct 9, 2023